EN PL

EMA: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

26.07.2012
This guidance document addresses a number of questions which marketing authorisation holders (MAHs) may have on post-authorisation procedures. It provides an overview of the Agency’s position on issues, which are typically addressed in discussions or meetings with MAHs in the post-authorisation phase.